ArticleThoracic cancer2022

MiR-192/NKRF axis confers lung cancer cell chemoresistance to cisplatin via the NF-κB pathway.

Yang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.